SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddys gets US FDA nod for Generic Navelbine injection

17 Sep 2013 Evaluate

Pharma major Dr Reddys Laboratories has received US Food and Drug Administration (FDA) approval for Generic Navelbine injection. The said injection is anti-cancer chemotherapy drug which used for Non-small cell lung cancer. Moreover, some healthcare providers may also give Navelbine for breast cancer, ovarian cancer, or Hodgkin’s disease.

Dr Reddys is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Labs. Share Price

1346.95 -29.35 (-2.13%)
30-Jun-2026 09:49 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1878.85
Dr. Reddys Labs. 1346.95
Cipla 1455.30
Zydus Lifesciences 1126.60
Lupin 2394.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: